Canadian in Biological Technology

Dow AgroSciences, Monsanto Complete U.S. and Canadian Regulatory Authorizations for SmartStax Corn; Plans Set to Launch Seed Platform on 3 Million- to 4 Million-Plus Acres

INDIANAPOLIS and ST. LOUIS, July 20 /PRNewswire-FirstCall/ -- U.S. and Canadian farmers are one step closer to realizing the greater whole farm corn yield advantages of a new corn seed trait combination that will provide the most comprehensive insect and weed control and allow farme...

BioMS Medical to present at the 2009 Symposium for the Canadian Society for Pharmaceutical Sciences

Toronto Stock Exchange Symbol: MS EDMONTON, May 28 /PRNewswire-FirstCall/ - BioMS Medical Corp (TSX: MS), a leading developer in the treatment of multiple sclerosis (MS), today announced that Mr. Randy Stroud, Vice President Regulatory Affairs, will present at the Canadian Society for Pharmac...

DuPont Receives Canadian Regulatory Approval for High Oleic Soybean Trait

Next Generation Healthy Soybean Oil Trait Will Benefit Everyone from Farmers to Consumers. Wilmington, DE (Vocus) May 11, 2009 -- DuPont today announced it has reached a regulatory milestone for its next generation of healthier soybean products. DuPont business Pion...

Vancouver General Hospital is the First Canadian Institution to Implement Copan WASP(R): Walk-Away Specimen Processor

MURRIETA, Calif., April 9 /PRNewswire/ -- Copan Diagnostics, Inc. is proud to announce the first installation of WASP(R): Walk-Away Specimen Processor in Canada at Vancouver General Hospital. Copan WASP(R): Walk-Away Specimen Processor is a revolutionary system for automatic planting and streaking...

Leading Canadian Scientist to speak at UN Climate Change Conference

Dr. David Dennis will Outline How Technology Can Solve Pressing Food, Fuel Problems of the 21st Century KINGSTON, ON, Dec. 3 /PRNewswire/ - Dr. David Dennis, FRSC, CEO of Performance Plants Inc. (PPI), is one of four leading experts speaking at a side event at the United Nations...

GeneNews appoints Canadian Colorectal Cancer Advisory Board

TORONTO, Nov. 19 /PRNewswire-FirstCall/ - GeneNews Limited (TSX: GEN), a company focused on developing blood-based biomarker tests for the early detection of diseases and personalized health management, today announced the formation of a Canadian Colorectal Cancer Advisory Board. Drs. Lawrence Coh...

Medizone International, Inc. Announces Establishment of Canadian Foundation for Global Health

SAN FRANCISCO, Oct. 30 /PRNewswire-FirstCall/ -- Medizone International, Inc. (Pink Sheets: MZEI) is pleased to announce the formal establishment of a not-for-profit affiliate, the Canadian Foundation for Global Health (CFGH). CFGH was founded under Canadian Federal Law as a not-for-profit Can...

BioElectronics Announces Significant Progress in Canadian and International Distribution

Strong sales progress being made as distribution channel reorders continue FREDERICK, Md., Oct. 21 /PRNewswire/ -- BioElectronics Corp. (BIEL), the maker of ActiPatch(R) Therapy, the drug free anti-inflammatory patch, with an embedded battery operated microchip delivering continuous pulse th...

Reliant Technologies Announces Canadian Launch of Fraxel re:pair(R) Laser: A New Class of Treatment Therapy for CO2 Laser Skin Resurfacing

Fraxel re:pair(R) system receives Health Canada clearance to treat severe sun damage, sagging skin, vascular dyschromia and wrinkles MOUNTAIN VIEW, Calif., Aug. 19 /PRNewswire/ -- Reliant Technologies, Inc., the pioneer of fractional resurfacing and market leader of aesthetic laser skin t...

Healthation Chosen by Large Canadian Third Party Administrator to Support All Employee Benefits and Claims Administration

DARIEN, Ill., July 1 /PRNewswire/ -- Healthation, a healthcare technology company, announced today they have signed a large Canadian Third Party Administrator (TPA) to a 10 year contract. The Canadian TPA will use the integrated real-time, rules-based AcceleHealth(R) benefits and claims soluti...

Allegiance Equity Corporation announces collaboration with Canadian Dairy Commission and Guelph Food Technologies Corporation for Alzheimers and Dementia formulation GG-XT

(TSX-V "ANQ") Canadian Dairy Commission funds formulation of two beverages with GG-XT at Guelph Food Technologies. TORONTO, June 23 /PRNewswire-FirstCall/ - The Canadian Dairy Commission has funded the formulation of two dairy beverages with ...

ATS Medical Announces Canadian Regulatory Approval of the ATS Open Pivot AP360 Mechanical Heart Valve

MINNEAPOLIS, June 23 /PRNewswire-FirstCall/ -- ATS Medical, Inc. (Nasdaq: ATSI ), manufacturer and marketer of state-of-the-art cardiac surgery products and services, today announced Health Canada -- Medical Device Bureau, Therapeutic Products Programme has approved use of the ATS Open Pivot(...

Aortic Stent Grafts Will Boost Canadian and Japanese Peripheral Vascular Markets

Japanese and Canadian aortic stent graft market to grow at CAGRs of nearly 60% and 20%, respectively, through 2012, according to Millennium Research Group WALTHAM, Mass., June 19 /PRNewswire/ -- According to Millennium Research Group's Japanese Markets for Perip...

New discoveries, new labs highlight international Canadian Light Source meeting

SASKATOON, SASKATCHEWAN Discoveries by some of Canada's brightest researchers will be the focus of the Canadian Light Source (CLS) 11th Annual Users' Meeting. The meeting is part of a joint conference that also includes the fifth International Workshop on Mechanical Engineering Design of Synchrotr...

Oncolytics Biotech Inc. Announces Issuance of 9th Canadian Patent

CALGARY, May 23 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. (TSX: ONC, NASDAQ: ONCY) ("Oncolytics") today announced it has been granted Canadian Patent 2,360,833 entitled "Reovirus for the Treatment of Cellular Proliferative Disorders." The claims describe the use of one or more recombina...

Angiotech's Corporate Partner, Boston Scientific, Reports Canadian Approval for TAXUS(R) Liberte(R) Stent System

VANCOUVER, April 18 /PRNewswire-FirstCall/ - Angiotech Pharmaceuticals, Inc. (NASDAQ: ANPI , TSX: ANP), a global specialty pharmaceutical and medical device company, today reported that its corporate partner, Boston Scientific Corporation "BSC" (NYSE: BSX ) has received approval for the sale...

Boston Scientific Receives Canadian Approval for TAXUS(R) Liberte(R) Stent System

Company plans to launch product immediately NATICK, Mass., April 17 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX ) today announced that it has received approval for the sale of its TAXUS(R) Liberte(R) paclitaxel-eluting coronary stent system in Canada. The ...

CSL Behring Signs Agreements With Canadian Blood Services and Hema-Quebec to Supply Life-Saving Therapies

-Company Joins Supplier Base Offering Broad Array of Healthcare Products to Patients with Immune Deficiency and Bleeding Disorders OTTAWA, April 3, 2008 /PRNewswire/ -- CSL Behring Canada, Inc. today announced that Canadian Blood Services, and Hema-Quebec, have each awarded the company c...

BioElectronics Announces Canadian Retail Product Launch

Drug Stores and Mass Merchandisers to Sell Unique Back and Other Pain Products FREDERICK, Md., Feb. 5 /PRNewswire-FirstCall/ -- BioElectronics Corporation, (Pink Sheets: BIEL), announced today that it has signed a sales, marketing and distribution agreement with...

Kiwa Bio-Tech Products Group Discusses Cooperative Efforts With Canadian Agricultural Ministry and Canadian Company

BEIJING and CLAREMONT, Calif., Feb. 4 /Xinhua-PRNewswire-FirstCall/ -- (OTC Bulletin Board: KWBT) Kiwa Bio-Tech Products Group Corporation's CEO and Board Chairman, Mr. Wei Li, met to discuss cooperative ventures with members of the Canadian Agricultural Ministry and Natunola Health, Inc. of O...

Oncolytics Biotech Inc. Announces Issuance of 8th Canadian Patent

CALGARY, Jan. 29 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. (TSX: ONC, NASDAQ: ONCY) ("Oncolytics") has been granted Canadian Patent 2,408,251 entitled "Clearance of Neoplastic Cells from Mixed Cellular Compositions using Viruses." The claims describe methods of selectively removing canc...

The Government of Quebec and the New Canadian Government Invest in the Creation of an International Biobank

Genome Quebec and the Centre de sante et de services sociaux de Chicoutimi launch the Genome Quebec-Centre hospitalier affilie universitaire regional de Chicoutimi Biobank SAGUENAY, Quebec, Aug. 21 /PRNewswire/ -- The Honourable Jean-Pierre Blackburn, Minister of Labour...

EraGen signs Canadian Market Distribution Agreement for nucleic acid dection products

MADISON - EraGen Biosciences , announced today they have signed a distribution agreement with Inter Medico , Canada's leading independent distributor of advanced clinical in-vitro diagnostic products. The announcement follows the companys distribution agreement announced last Wednesday with Prome...

Standard Imaging acquires Canadian PIPSpro radiation treatment technologies

Middleton, Wis. Standard Imaging , a Middleton-based provider of testing instruments used in support of radiation treatment for cancer cardiology and other applications, has announced the purchase of Masthead Imagings assets. Among the assets acquired from the British Columbia-based company are...

Standard Imaging acquires Canadian PIPSpro radiation treatment technologies

Middleton, Wis. Standard Imaging , a Middleton-based provider of testing instruments used in support of radiation treatment for cancer cardiology and other applications, has announced the purchase of Masthead Imaging s assets. Among the assets acquired from the British Columbia-based company are...

Merge eFilm corporate merger with Canadian firm moves ahead

Milwaukee The all-stock merger between Merge Technologies Inc., a health-care software and services company, and Canadian firm Cedara Software Corp. will move forward with approval from Merge shareholders. According to a statement from Merge, company officials expect the merger to be finished...

Take off: Canadian biotech industry thrives

Last week, we looked at Israeli life sciences and the high density of activities occurring in the small country. This week, your world-traveling columnist takes you north of the border to Canada where he participated in an event offered by the Toronto Biotechnology Initiative . You may ask wh...

GE Healthcare enters agreement with Canadian health authority

Waukesha, Wis . - GE Healthcare and the Vancouver Island Health Authority (VIHA) have signed an eight-year, $11 million agreement under which the authority would purchase 48 new ultrasound systems. The VIHA will receive GE's most advanced ultrasound technologies and establish new clinical ...

OncoGenex Reports Second Quarter 2009 Financial Results

...RED) claim, which offset R D expenses in that period. The SRED program is a canadian federal tax incentive program that encourages canadian businesses to conduct research and development in Canada. As OncoGenex Tech...

Oncothyreon announces webcast of second quarter 2009 financial results conference call

...ounced that it intends to release its second quarter and year end 2009 financial results on Wednesday, August 12, 2009 after the close of the U.S. and canadian markets. Following the release, Oncothyreon's management expects to discuss these financial results and give a general business update in a conference...

Angiotech Pharmaceuticals, Inc. announces financial results for the second quarter ended June 30, 2009

...d constitute "forward-looking information" within the meaning of applicable canadian securities laws. All such statements are made pursuant to the "safe harbor"...; and any other factors referenced in our other filings with the applicable canadian securities regulatory authorities or the Securities and Exchange Commission...

Exciton Technologies receives FDA approval to market exSALT(TM)

...ay be subsequently shown to be invalid or infringe the patents of others. Investors should consult the Company's quarterly and annual filings with the canadian commissions for additional information on risks and uncertainties relating to the forward- looking statements. Investors are cautioned against placing...

ImmunoVaccine Technologies Partners With Scancell to Advance DNA Vaccine Delivery

... HALIFAX, NS, Aug. 5 /PRNewswire/ - ImmunoVaccine Technologies Inc. (IVT), a canadian vaccine development company, has signed an agreement with UK-based Scancell Ltd., the operating company of Scancell Holdings Plc (SCLP.PL), which is d...

Oncothyreon appoints Diana Hausman as Vice President of Clinical Development

...linical trials. These and other risks and uncertainties are described in the reports and other documents filed by Oncothyreon Inc. with the SEC and/or canadian regulatory authorities. Although Oncothyreon believes that any forward-looking statements contained herein are reasonable, it can give no assurance ...

Angiotech Pharmaceuticals announces launch of Quill SRS product codes for laparoscopic gynecology procedures

... of 1995 and "forward-looking information" within the meaning of applicable canadian securities laws. All such statements are made pursuant to the "safe harbor"... filings with the Securities and Exchange Commission ("SEC") and applicable canadian regulatory authorities. For a more thorough discussion of the risks associa...

Oncothyreon announces presentation of long-term Stimuvax data at World Conference on Lung Cancer

...linical trials. These and other risks and uncertainties are described in the reports and other documents filed by Oncothyreon Inc. with the SEC and/or canadian regulatory authorities. Although Oncothyreon believes that any forward-looking statements contained herein are reasonable, it can give no assurance ...

AEterna Zentaris Partner, Keryx, Announces Agreement with FDA on a Special Protocol Assessment for Phase 3 Trial with Perifosine (KRX-0401) for the Treatment of Multiple Myeloma

...ted to the regulatory process and general changes in economic conditions. Investors should consult the Company's quarterly and annual filings with the canadian and U.S. securities commissions for additional information on risks and uncertainties relating to the forward-looking statements. Investors are cautio...

Oncolytics Biotech(R) Inc. Announces 2009 Second Quarter Results

...o the regulatory process and general changes to the economic environment. Investors should consult the Company's quarterly and annual filings with the canadian and U.S. securities commissions for additional information on risks and uncertainties relating to the forward-looking statements. Investors are cautio...

Oncolytics Biotech Inc. Successfully Completes 100-Litre cGMP Production of REOLYSIN(R)

...t of pharmaceuticals and uncertainties related to the regulatory process. Investors should consult the Company's quarterly and annual filings with the canadian and U.S. securities commissions for additional information on risks and uncertainties relating to the forward-looking statements. Investors are cautio...

Angiotech Pharmaceuticals, Inc. announces filing of shelf-registration statement

... of 1995 and "forward-looking information" within the meaning of applicable canadian securities laws. All such statements are made pursuant to the "safe harbor"... filings with the Securities and Exchange Commission ("SEC") and applicable canadian regulatory authorities. For a more thorough discussion of the risks associa...